K110137Substantially Equivalent
Abx Pentra Enzymatic Creatinine Cp, Abx Pentra Multical, Abx Pentra N Control, Abx Pentra P Control, and Abx Pentra Urin
Horiba Abx SAS, Montpellier, FR / Abbreviated, Substantially Equivalent
K110137 is the FDA 510(k) clearance record for ABX PENTRA ENZYMATIC CREATININE CP, ABX PENTRA MULTICAL, ABX PENTRA N CONTROL, ABX PENTRA P CONTROL, AND ABX PENTRA URIN, a class II device, cleared for HORIBA ABX SAS on under FDA product code JFY (Enzymatic Method, Creatinine). FDA records list 17 510(k) clearances for HORIBA ABX SAS, from to . As of , FDA records show 2 recalls naming K110137.
Clearance record
- Decision date
- Received
- (204 days to decision)
- Product code
- JFY Enzymatic Method, Creatinine
- Regulation
- 21 CFR 862.1225
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Applicant
- Horiba Abx Sas Parc Euromedecine, Montpellier, FR
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code JFY
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 1 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
